Get started
Live feed
·
SECFilingvia Quantisnow
Oric Pharmaceuticals Inc. logo

ORIC: SEC Form 8-K filed by Oric Pharmaceuticals Inc.

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for ORIC

Across the 28 sessions after earlier ORIC headlines, the stock closed higher 12 times and lower 15 times, with a median move of 2.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

ORIC close-to-close change in the session after earlier headlines
SessionEarlier headlineORICSPY
Oct 23, 2026ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026and 1 other headline that session-3.4%-0.5%
Oct 19, 2026ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026+3.0%+0.4%
Oct 6, 2026ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development-4.1%+0.5%
Oct 5, 2026Leerink Partners initiated coverage on ORIC Pharmaceuticals with a new price targetand 1 other headline that session+2.3%+0.7%
Sep 23, 2026BTIG Research initiated coverage on ORIC Pharmaceuticals with a new price target-1.3%-0.7%
Sep 8, 2026ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)-1.9%-0.5%
Quantisnow market dataNASDAQ
Oric Pharmaceuticals Inc. logo
ORIC
Oric Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2020
Get push alerts for ORIC

Follow ORIC and get a push notification the moment its next story breaks.

Full ORIC profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORIC (Oric Pharmaceuticals Inc.) and more on Quantisnow.